Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INSMED Inc | 246,081 | reported | 13 May 2026 | tx 126+789,218.5−232,132 |
| ANDRX CORP /DE/ | 0 | reported | 03 Nov 2006 | tx 20+13,631−493,442 |
| PAR PHARMACEUTICAL COMPANIES, INC. | 0 | reported | 28 Sept 2012 | tx 45+57,791−65,291 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2026 | GRANT_AWARD | INSMED Inc | 3,305 | — | |
| 03 Mar 2026 | GIFT | INSMED Inc | 100 | 0.00 USD | |
| 25 Feb 2026 | GIFT | INSMED Inc | 243 | 0.00 USD | |
| 25 Feb 2026 | GIFT | INSMED Inc | 243 | 0.00 USD | |
| 25 Feb 2026 | GIFT | INSMED Inc | 243 | 0.00 USD | |
| 25 Feb 2026 | GIFT | INSMED Inc | 243 | 0.00 USD | |
| 25 Feb 2026 | GIFT | INSMED Inc | 1,072 | 0.00 USD | |
| 05 Dec 2025 | SALE | INSMED Inc | 20,000 | 205.01 USD | |
| 11 Sept 2025 | GIFT | INSMED Inc | 2,000 | 0.00 USD | |
| 11 Sept 2025 | GIFT | INSMED Inc | 159 | 0.00 USD | |
| 11 Sept 2025 | GIFT | INSMED Inc | 159 | 0.00 USD | |
| 12 Sept 2025 | SALE | INSMED Inc | 10,000 | 145.39 USD | |
| 20 Aug 2025 | SALE | INSMED Inc | 10,000 | 129.50 USD | |
| 12 Aug 2025 | SALE | INSMED Inc | 10,000 | 121.58 USD | |
| 13 Aug 2025 | GIFT | INSMED Inc | 6,100 | 0.00 USD | |
| 13 Aug 2025 | GIFT | INSMED Inc | 15,000 | 0.00 USD | |
| 13 Aug 2025 | GIFT | INSMED Inc | 5,000 | 0.00 USD | |
| 27 May 2025 | GIFT | INSMED Inc | 200 | 0.00 USD | |
| 20 May 2025 | GIFT | INSMED Inc | 100 | 0.00 USD | |
| 20 May 2025 | GIFT | INSMED Inc | 400 | 0.00 USD | |
| 20 May 2025 | GIFT | INSMED Inc | 100 | 0.00 USD | |
| 20 May 2025 | GIFT | INSMED Inc | 100 | 0.00 USD | |
| 20 May 2025 | GIFT | INSMED Inc | 100 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | INSMED Inc | 5,058 | — | |
| 14 May 2025 | GIFT | INSMED Inc | 576 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 11 May 2022.